Skip to main content

Want a detailed portfolio tracker?

Alumis (ALMS) P/E (2024 - 2026)

Alumis (ALMS) P/E from Jun 28, 2024 to Jun 2, 2026. The TTM Alumis (ALMS) P/E is -7.02. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alumis (ALMS)

YearP/EChange
2026-7.02+176.40%
2025-2.54+1433.58%
2024-0.17N/A

Comparison Alumis (ALMS) P/E with competitors

Alumis (ALMS) P/E is -7.02.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.46%
ENLVEnlivex Therapeutics Ltd0.15-102.14%
FGENFibroGen Inc0.24-103.42%
TRAWTraws Pharma Inc0.47-106.74%
FBIOFortress Biotech Inc0.71-110.06%
CHRSCoherus Biosciences Inc0.98-113.94%
ORMPOramed Pharmaceuticals Inc1.47-120.99%
AGENAgenus Inc2.05-129.19%
VIVSVivoSim Labs Inc2.54-136.13%
INVAInnoviva Inc3.19-145.43%
CRMDCorMedix Inc3.65-151.94%
ABEOAbeona Therapeutics Inc4.20-159.91%
VXRTVaxart Inc4.26-160.72%
CVACCureVac N.V.4.45-163.34%
SRPTSarepta Therapeutics Inc4.62-165.89%
GLPGGalapagos NV4.86-169.23%
RIGLRigel Pharmaceuticals4.92-170.09%
ZVRAZevra Therapeutics Inc4.97-170.87%
ABUSArbutus Biopharma Corp5.69-181.12%
CGENCompugen Ltd7.38-205.21%
AUPHAurinia Pharmaceuticals Inc9.25-231.82%
ACADAcadia Pharmaceuticals Inc9.59-236.61%
OMEROmeros Corporation9.88-240.82%
PLXProtalix BioTherapeutics Inc9.91-241.19%
SPROSpero Therapeutics Inc10.73-252.95%
ADMAAdma Biologics Inc11.33-261.44%
SVASinovac Biotech Ltd11.44-262.94%
TBPHTheravance Biopharma Inc11.78-267.80%
HRMYHarmony Biosciences Holdings Inc12.18-273.55%
TGTXTG Therapeutics Inc13.18-287.78%
INCYIncyte Corp13.38-290.67%
SABSSAB Biotherapeutics Inc14.06-300.30%
XOMAXOMA Corp14.95-312.94%
REGNRegeneron Pharmaceuticals Inc14.98-313.44%
PBYIPuma Biotechnology Inc15.05-314.44%
EXELExelixis Inc15.79-325.05%
NAGENiagen Bioscience Inc16.35-333.03%
CPRXCatalyst Pharmaceuticals Inc17.34-347.13%
MDXGMimedx Group Inc17.38-347.57%
ARGXArgen X SE23.07-428.73%
HALOHalozyme Therapeutics Inc23.20-430.57%
XOMAOXOMA Corp25.34-461.12%
VRTXVertex Pharmaceuticals Inc25.66-465.55%
XOMAPXOMA Corp25.67-465.75%
CTMXCytomX Therapeutics Inc25.70-466.15%
ASNDAscendis Pharma A/S26.35-475.50%
RPRXRoyalty Pharma plc - Class A27.50-491.76%
SLNOSoleno Therapeutics Inc29.02-513.42%
LGNDLigand Pharmaceuticals Inc - Class B30.19-530.10%
BMRNBiomarin Pharmaceutical Inc37.51-634.41%
APLSApellis Pharmaceuticals Inc39.02-655.98%
KRYSKrystal Biotech Inc39.70-665.62%
GMABGenmab40.20-672.83%
ONCBeiGene Ltd67.03-1055.01%
TECHBio-Techne Corp68.59-1077.36%
VCELVericel Corp80.63-1248.82%
PHARPharming Group N.V.87.74-1350.14%
TLXTelix Pharmaceuticals Ltd139.89-2093.19%
CORTCorcept Therapeutics Inc158.39-2356.76%